AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19861187 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized mumps vaccine (Leningrad-Zagreb strain)
Number of subjects: 0
Study 18720121 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training with the AirHeel Brace
Number of subjects: 116
Study 18720121 — intervention group
Group type: COMPARATOR
Intervention: Eccentric training without the AirHeel Brace
Number of subjects: 116
Study 12081199 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term preoperative radiotherapy (5 x 5 Gy)
Number of subjects: 1306
Study 12081199 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative radiotherapy)
Number of subjects: 1306
Study 9833911 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (30 mg per day initially, tapered to 10 mg daily after 8 weeks) and azathioprine (50 mg daily)
Number of subjects: 50
Study 9833911 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 7978715 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg twice daily
Number of subjects: 154
Study 7978715 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 1000 mg twice daily
Number of subjects: 154
Study 7978715 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin 2000 mg twice daily
Number of subjects: 154
Study 7978715 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin (all dosages)
Number of subjects: 154
Study 2688237 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (lidocaine/prilocaine)
Number of subjects: 13
Study 2688237 — intervention group
Group type: COMPARATOR
Intervention: Infiltration analgesia with 1% carbocaine (mepivacaine)
Number of subjects: 13
Study 999302 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil and 0.5% triamcinolone acetonide cream
Number of subjects: 0
Study 999302 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil alone
Number of subjects: 0
Study 999302 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted (0.1%) triamcinolone acetonide cream
Number of subjects: 0
Study 31692152 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted 10% higher CRP concentration
Number of subjects: 991
Study 31692152 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma CRP ≥2.0 mg/l
Number of subjects: 991
Study 30649381 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 0
Study 30649381 — intervention group
Group type: COMPARATOR
Intervention: Artesunate-mefloquine (ASMQ)
Number of subjects: 0
Study 26869229 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-minute clown visit
Number of subjects: 200
Study 26869229 — intervention group
Group type: COMPARATOR
Intervention: 10-minute humorous video clip
Number of subjects: 200
Study 26059332 — intervention group
Group type: EXPERIMENTAL
Intervention: Selumetinib 75 mg twice daily in combination with dacarbazine 1000 mg/m² on Day 1 of every 21-day cycle
Number of subjects: 128
Study 26059332 — intervention group
Group type: COMPARATOR
Intervention: Dacarbazine 1000 mg/m²
Number of subjects: 128
Study 23493728 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryptococcal-specific CD4(+) T-cell responses characterized by IFN-γ and TNF-α production
Number of subjects: 44
Study 21705396 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture + relaxation response (AR)
Number of subjects: 130
Study 21705396 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture + relaxation response (SR)
Number of subjects: 130
Study 21705396 — intervention group
Group type: COMPARATOR
Intervention: Real acupuncture + health education (AE)
Number of subjects: 130
Study 21705396 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture + health education (SE)
Number of subjects: 130
Study 19098188 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided percutaneous catheter drainage in patients with sterile necrosis
Number of subjects: 35
Study 19098188 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided percutaneous catheter drainage in patients with infected necrosis
Number of subjects: 35
Study 19098188 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided percutaneous catheter drainage in patients with multisystem organ failure
Number of subjects: 35
Study 19098188 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-guided percutaneous catheter drainage in patients without multisystem organ failure
Number of subjects: 35
Study 16699660 — intervention group
Group type: EXPERIMENTAL
Intervention: SITA Standard (SS)
Number of subjects: 31
Study 16699660 — intervention group
Group type: COMPARATOR
Intervention: Full Threshold (FT)
Number of subjects: 31
Study 15302454 — intervention group
Group type: EXPERIMENTAL
Intervention: Opalescence 10% (O10)
Number of subjects: 60
Study 15302454 — intervention group
Group type: EXPERIMENTAL
Intervention: Opalescence 15% (O15)
Number of subjects: 60
Study 15302454 — intervention group
Group type: EXPERIMENTAL
Intervention: Opalescence 20% (O20)
Number of subjects: 60
Study 15302454 — intervention group
Group type: EXPERIMENTAL
Intervention: Whiteness 10% (W10)
Number of subjects: 60
Study 15302454 — intervention group
Group type: EXPERIMENTAL
Intervention: Whiteness 16% (W16)
Number of subjects: 60
Study 15302454 — intervention group
Group type: COMPARATOR
Intervention: Control (C-untreated)
Number of subjects: 60
Study 11770869 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 14
Study 11770869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 9832976 — intervention group
Group type: EXPERIMENTAL
Intervention: Monetary incentive
Number of subjects: 44
Study 9832976 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa (100 mg) and benserazide (25 mg)
Number of subjects: 44
Study 9832976 — intervention group
Group type: COMPARATOR
Intervention: Control (no incentive)
Number of subjects: 44
Study 9832976 — intervention group
Group type: COMPARATOR
Intervention: Control (no levodopa)
Number of subjects: 44
Study 8508870 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose intravenous antibiotic prophylaxis (4 g piperacillin and 800 mg tinidazole 30 minutes before surgery)
Number of subjects: 66
Study 8508870 — intervention group
Group type: COMPARATOR
Intervention: Multiple dose intravenous antibiotic prophylaxis (4 g piperacillin 30 minutes before surgery, 4 g piperacillin 8 hours after, and 4 g piperacillin and 800 mg tinidazole 16 hours after the first dose)
Number of subjects: 66
Study 31034033 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 961
Study 31034033 — intervention group
Group type: COMPARATOR
Intervention: Non-LNS groups (iron and folic acid + calcium, multiple micronutrients)
Number of subjects: 961
Study 29436896 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined music and Tai Chi for three months
Number of subjects: 107
Study 29436896 — intervention group
Group type: COMPARATOR
Intervention: Routine health education delivered monthly by community nurses (Control)
Number of subjects: 107
Study 26865496 — intervention group
Group type: EXPERIMENTAL
Intervention: Center-based physical activity (PA) intervention for a median of 2.7 years
Number of subjects: 1633
Study 26865496 — intervention group
Group type: COMPARATOR
Intervention: Health education (control group) for a median of 2.7 years
Number of subjects: 1633
Study 23345601 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/day avocado-soybean unsaponifiable (ASU-E)
Number of subjects: 399
Study 23345601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study 23060025 — intervention group
Group type: COMPARATOR
Intervention: Combined trabeculotomy‐trabeculectomy with mitomycin C (CTTM)
Number of subjects: 20
Study 23060025 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined trabeculotomy‐trabeculectomy with mitomycin C and deep sclerectomy (CTTM-DS)
Number of subjects: 20
Study 23060025 — intervention group
Group type: COMPARATOR
Intervention: CTTM
Number of subjects: 20
Study 23060025 — intervention group
Group type: EXPERIMENTAL
Intervention: CTTM-DS
Number of subjects: 20
Study 21568147 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard triple therapy (Group A): omeprazole, amoxicillin, metronidazole, and bismuth, twice daily for 2 weeks
Number of subjects: 428
Study 21568147 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin based triple therapy (Group C): omeprazole and amoxicillin, twice daily for 2 weeks, and ciprofloxacin twice a day for the first week
Number of subjects: 428
Study 21568147 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple therapy (Group D): omeprazole, amoxicillin for 5 days, followed by omeprazole, clarithromycin, and metronidazole for the remaining 5 days, all twice daily for 10 days
Number of subjects: 428
Study 21568147 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B): omeprazole, amoxicillin, and clarithromycin, twice daily for 10 days
Number of subjects: 428
Study 18082484 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacoinvasive strategy (transfer for routine PCI within 6 hours of fibrinolysis)
Number of subjects: 1200
Study 18082484 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment after fibrinolysis
Number of subjects: 1200
Study 16513681 — intervention group
Group type: EXPERIMENTAL
Intervention: A23G SNP in XPA (GG genotype)
Number of subjects: 886
Study 16513681 — intervention group
Group type: EXPERIMENTAL
Intervention: XPA genotype
Number of subjects: 886
Study 16513681 — intervention group
Group type: EXPERIMENTAL
Intervention: XPA haplotypes
Number of subjects: 886
Study 14966633 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline slow-release gel
Number of subjects: 30
Study 11113239 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g Cr/day for 4 weeks
Number of subjects: 16
Study 11113239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9229987 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil with isoflurane
Number of subjects: 40
Study 9229987 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil with propofol
Number of subjects: 40
Study 8232134 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen mouth wash 10 ml, 3 times daily for 7 days
Number of subjects: 60
Study 8232134 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth wash 10 ml, 3 times daily for 7 days
Number of subjects: 60
Study 8232134 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 3457810 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% chlorhexidine (CH)
Number of subjects: 23
Study 3457810 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% metronidazole (MD)
Number of subjects: 23
Study 3457810 — intervention group
Group type: COMPARATOR
Intervention: 0.01% quinine sulphate inactive control (PL)
Number of subjects: 23
Study 30857410 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure therapy (target systolic blood pressure <120 mm Hg)
Number of subjects: 14094
Study 30857410 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure treatment (target <140 mm Hg)
Number of subjects: 14094
Study 30857410 — intervention group
Group type: COMPARATOR
Intervention: Logistic regression approach
Number of subjects: 14094
Study 30857410 — intervention group
Group type: EXPERIMENTAL
Intervention: X-learner approach
Number of subjects: 14094
Study 29435996 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II minimally‐invasive extracorporeal circuit (MiECC)
Number of subjects: 50
Study 29435996 — intervention group
Group type: COMPARATOR
Intervention: Conventional extracorporeal circuits (CECC)
Number of subjects: 50
Study 26821688 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadripolar LV lead
Number of subjects: 43
Study 26821688 — intervention group
Group type: COMPARATOR
Intervention: Bipolar LV lead
Number of subjects: 43
Study 25415695 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kV with 90 mL iopromide 370 mg I/mL at 3.5 mL/s
Number of subjects: 83
Study 25415695 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kV with 44% reduction in contrast volume
Number of subjects: 83
Study 23017784 — intervention group
Group type: EXPERIMENTAL
Intervention: Cola (1 liter daily)
Number of subjects: 13
Study 23017784 — intervention group
Group type: COMPARATOR
Intervention: Deionized water (1 liter daily)
Number of subjects: 13
Study 20415698 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan (250 mg)
Number of subjects: 10
Study 20415698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 20415698 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 10
Study 18001455 — intervention group
Group type: EXPERIMENTAL
Intervention: Total salpingectomy during abdominal hysterectomy (Group 1)
Number of subjects: 24
Study 18001455 — intervention group
Group type: COMPARATOR
Intervention: Partial removal of fallopian tubes during abdominal hysterectomy (Group 2)
Number of subjects: 24
Study 15664574 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided diagnosis (CAD) system
Number of subjects: 20
Study 15664574 — intervention group
Group type: COMPARATOR
Intervention: Experienced chest radiologists
Number of subjects: 20
Study 15664574 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus with CAD
Number of subjects: 20
Study 12391944 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital at-home care
Number of subjects: 42
Study 12391944 — intervention group
Group type: COMPARATOR
Intervention: Hospital day-care unit
Number of subjects: 42
Study 12391944 — intervention group
Group type: EXPERIMENTAL
Intervention: Home care
Number of subjects: 42
Study 12391944 — intervention group
Group type: COMPARATOR
Intervention: Hospital care
Number of subjects: 42
Study 9931532 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (1 mg/m2/d)
Number of subjects: 54
Study 7772643 — intervention group
Group type: EXPERIMENTAL
Intervention: Metyrapone 750 mg followed by oCRF 0.3 microgram/kg
Number of subjects: 20
Study 7772643 — intervention group
Group type: COMPARATOR
Intervention: oCRF following metyrapone pretreatment
Number of subjects: 20
Study 1969869 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol 25 micrograms escalating to 100 micrograms, and 100 micrograms twice daily
Number of subjects: 45
Study 1969869 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol
Number of subjects: 45
Study 1969869 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose of procaterol
Number of subjects: 45
Study 375050 — intervention group
Group type: EXPERIMENTAL
Intervention: Alice/R‐75 2-dose vaccine
Number of subjects: 319
Study 375050 — intervention group
Group type: EXPERIMENTAL
Intervention: Alice/R‐75 1-dose vaccine
Number of subjects: 319
Study 375050 — intervention group
Group type: COMPARATOR
Intervention: Placebo 2-dose
Number of subjects: 319
Study 375050 — intervention group
Group type: EXPERIMENTAL
Intervention: Alice strain monovalent influenza A vaccine
Number of subjects: 319
Study 375050 — intervention group
Group type: EXPERIMENTAL
Intervention: R‐75 strain monovalent vaccine
Number of subjects: 319
Study 31753903 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face training with certified instructor, using Laerdal Little Anne manikins for 20 minutes.
Number of subjects: 50000
Study 31753903 — intervention group
Group type: COMPARATOR
Intervention: Virtual reality training using the Lifesaver VR app for 20 minutes, practicing on a pillow while wearing VR goggles and headphones.
Number of subjects: 50000
Study 31753903 — intervention group
Group type: EXPERIMENTAL
Intervention: Both training methods (face-to-face and VR) evaluated for overall CPR performance using a European Resuscitation Council endorsed checklist.
Number of subjects: 50000
Study 31753903 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up questionnaires post-training.
Number of subjects: 50000
Study 28189659 — intervention group
Group type: EXPERIMENTAL
Intervention: HemCon Dental Dressing (HDD)
Number of subjects: 20
Study 28189659 — intervention group
Group type: COMPARATOR
Intervention: Common hemostatic sponge (CollaPlug, Zimmer Dental)
Number of subjects: 20
Study 26183257 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster Sets (CLU) [4 × (2 × 5) with 1.5 min rest between sets and 30 s rest between clusters]
Number of subjects: 23
Study 26183257 — intervention group
Group type: COMPARATOR
Intervention: Traditional Sets (TRD) [4 × 10 repetitions with 2 min rest]
Number of subjects: 23
Study 26183257 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster Sets (CLU)
Number of subjects: 23
Study 26183257 — intervention group
Group type: COMPARATOR
Intervention: Traditional Sets (TRD)
Number of subjects: 23
Study 26183257 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions (CLU and TRD)
Number of subjects: 23
Study 23191994 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fibre LGI diet
Number of subjects: 16
Study 23191994 — intervention group
Group type: COMPARATOR
Intervention: Lower-fibre HGI diet
Number of subjects: 16
Study 20569998 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 70
Study 20569998 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 70
Study 19387173 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous insulin infusion (target glucose 100-150 mg/dl)
Number of subjects: 236
Study 19387173 — intervention group
Group type: COMPARATOR
Intervention: Standard intermittent insulin bolus (treat glucose > 150 mg/dl)
Number of subjects: 236
Study 19387173 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous insulin infusion
Number of subjects: 236
Study 19387173 — intervention group
Group type: COMPARATOR
Intervention: Standard intermittent insulin bolus
Number of subjects: 236
Study 17290437 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 104
Study 17290437 — intervention group
Group type: COMPARATOR
Intervention: Cobalt-chromium stent (CCS)
Number of subjects: 104
Study 14522441 — intervention group
Group type: EXPERIMENTAL
Intervention: N'Dribala (Cochlospermum planchonii)
Number of subjects: 85
Study 14522441 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 85
Study 11128858 — intervention group
Group type: EXPERIMENTAL
Intervention: GAKIC (glycine and L-arginine salt of alpha-ketoisocaproic acid calcium)
Number of subjects: 13
Study 11128858 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric sucrose (control)
Number of subjects: 13
Study 9202586 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI with criterion 1 (lymph node diameter > 1.0 cm)
Number of subjects: 216
Study 9202586 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI with criterion 2 (lymph node diameter > 0.5 cm with asymmetry)
Number of subjects: 216
Study 9202586 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal small asymmetric lymph nodes
Number of subjects: 216
Study 1487885 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogranulong 5.2 mg
Number of subjects: 10
Study 1487885 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogranulong 10.4 mg
Number of subjects: 10
Study 1487885 — intervention group
Group type: EXPERIMENTAL
Intervention: Trinitrolong 2 mg
Number of subjects: 10
Study 1487885 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrong 6.5 mg
Number of subjects: 10
Study 1487885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3954919 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 80
Study 3954919 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 80
Study 31919911 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary energy level (increased)
Number of subjects: 60
Study 31236810 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) for 8 weeks, 3 times per week on a cycle ergometer
Number of subjects: 30
Study 31236810 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control (CON) group
Number of subjects: 30
Study 28414741 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfamiliar relaxing music
Number of subjects: 12
Study 28414741 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfamiliar arousing music
Number of subjects: 12
Study 25623589 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic (oral sultamicillin) for five days
Number of subjects: 980
Study 25623589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 980
Study 23931538 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelling group (received modelling examples during training)
Number of subjects: 48
Study 23931538 — intervention group
Group type: COMPARATOR
Intervention: Control group (no modelling examples during training)
Number of subjects: 48
Study 21292059 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 16
Study 21292059 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 16
Study 19074931 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary counselling and food fortification
Number of subjects: 59
Study 19074931 — intervention group
Group type: COMPARATOR
Intervention: Dietary advice leaflet (Control)
Number of subjects: 59
Study 16621446 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine administration
Number of subjects: 40
Study 16621446 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 15641866 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg mirtazapine
Number of subjects: 70
Study 15641866 — intervention group
Group type: COMPARATOR
Intervention: No antidepressant medication (control group)
Number of subjects: 70
Study 15641866 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg mirtazapine (for treatment after diagnosis)
Number of subjects: 70
Study 11157324 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine intake (graded intake)
Number of subjects: 6
Study 11157324 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine intake (safe intake)
Number of subjects: 6
Study 9573545 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine infusion (30 g)
Number of subjects: 8
Study 9573545 — intervention group
Group type: COMPARATOR
Intervention: Control infusion (30 g branched chain amino acids)
Number of subjects: 8
Study 7836512 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography monitoring
Number of subjects: 114
Study 7836512 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonography and serum determinations
Number of subjects: 114